179 related articles for article (PubMed ID: 202709)
1. 5-O-Alkylated derivatives of 5-hydroxy-2'-deoxyuridine as potential antiviral agents. Anti-herpes activity of 5-propynyloxy-2'-deoxyuridine.
Torrence PF; Spencer JW; Bobst AM
J Med Chem; 1978 Feb; 21(2):228-31. PubMed ID: 202709
[TBL] [Abstract][Full Text] [Related]
2. Improved synthesis and in vitro antiviral activities of 5-cyanouridine and 5-cyano-2'-deoxyuridine.
Torrence PF; Bhooshan B
J Med Chem; 1977 Jul; 20(7):974-6. PubMed ID: 195058
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines.
Herdewijn P; De Clercq E; Balzarini J; Vanderhaeghe H
J Med Chem; 1985 May; 28(5):550-5. PubMed ID: 2985782
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activity of 5-[(cyanomethylene)oxy]-2'-deoxyuridine.
Huang GF; Okada M; De Clercq E; Torrence PF
J Med Chem; 1981 Apr; 24(4):390-3. PubMed ID: 6267280
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 5-[(methylthio)methyl]-2'-deoxyuridine, the corresponding sulfoxide and sulfone, and their 5'-phosphates: antiviral effects and thymidylate synthetase inhibition.
Schmidt CL; Chang CT; De Clercq E; Descamps J; Mertes MP
J Med Chem; 1980 Mar; 23(3):252-6. PubMed ID: 6245212
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of 5-ethyl pyrimidine deoxynucleosides.
De Clercq E; Shugar D
Biochem Pharmacol; 1975 May; 24(10):1073-8. PubMed ID: 168897
[No Abstract] [Full Text] [Related]
7. Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus.
De Clercq E; Rosenwirth B
Antimicrob Agents Chemother; 1985 Aug; 28(2):246-51. PubMed ID: 3010841
[TBL] [Abstract][Full Text] [Related]
8. Oxime and dithiolane derivatives of 5-formyl-2'-deoxyuridine and their 5'-phosphates: antiviral effects and thymidylate synthetase inhibition.
Park JS; Chang CT; Schmidt CL; Golander Y; De Clercq E; Descamps J; Mertes MP
J Med Chem; 1980 Jun; 23(6):661-5. PubMed ID: 6248643
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348
[TBL] [Abstract][Full Text] [Related]
10. (S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity.
De Clercq E; Descamps J; De Somer P; Holý A
Science; 1978 May; 200(4341):. PubMed ID: 205946
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1.
Bergstrom DE; Ruth JL; Reddy PA; De Clercq E
J Med Chem; 1984 Mar; 27(3):279-84. PubMed ID: 6321735
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of aliphatic nucleoside analogues: structure-function relationship.
De Clercq E; Holy A
J Med Chem; 1979 May; 22(5):510-3. PubMed ID: 222906
[TBL] [Abstract][Full Text] [Related]
13. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activities of arabinofuranosyl-5-ethylpyrimidine nucleosides. Selective antiherpes activity of 1-(beta-D-arabinofuranosyl)-5-ethyluracil.
Kulikowski T; Zawadzki Z; Shugar D; Descamps J; De Clercq E
J Med Chem; 1979 Jun; 22(6):647-53. PubMed ID: 222908
[No Abstract] [Full Text] [Related]
15. 5-Propyl-2'-deoxyuridine: a specific anti-herpes agent.
De Clercq E; Descamps J; Shugar D
Antimicrob Agents Chemother; 1978 Mar; 13(3):545-7. PubMed ID: 233730
[TBL] [Abstract][Full Text] [Related]
16. Antiviral and antimetabolic activities of formycin and its N1-, N2-, 2'-O- and 3'-O-methylated derivatives.
Giziewicz J; De Clercq E; Luczak M; Shugar D
Biochem Pharmacol; 1975 Oct; 24(19):1813-7. PubMed ID: 184795
[No Abstract] [Full Text] [Related]
17. Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.
Herrmann EC
Appl Microbiol; 1968 Aug; 16(8):1151-5. PubMed ID: 4300089
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.
Lee YS; Park SM; Kim BH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1126-8. PubMed ID: 19147352
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2'-deoxyuridine: preferential inhibition of herpes simplex virus type 2.
Teh CZ; Sacks SL
Antimicrob Agents Chemother; 1983 May; 23(5):637-40. PubMed ID: 6307130
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
Béres J; Sági G; Bentrude WG; Balzarini J; De Clercq E; Otvös L
J Med Chem; 1986 Jul; 29(7):1243-9. PubMed ID: 3027328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
